Comment on R.I. researchers disappointed by decision to halt study of Alzheimer's drug

R.I. researchers disappointed by decision to halt study of Alzheimer's drug

Leading Rhode Island researchers reacted with disappointment Friday to word that Cambridge-based pharmaceutical firm Biogen and its Japanese partner Eisai are stopping Phase 3 clinical trials of Aducanumab, a drug that had raised hopes of slowing the advance of Alzheimer’s disease.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News